AXIM

October 22, 2019

AXIM® Biotechnologies Nutraceutical Division Announces Cannabinoid-Based Wellness Gum …

Wellness Gum formulated with 5 mg of cannabidiol (CBD) and 25 mg of full-spectrum hemp oil. Wellness Gum PM formulated with 5…

Read More

June 27, 2017

AXIM Biotechnologies (OTCQB: AXIM) Takes on Opioid Epidemic with New Patent — SECFilings.com

AXIM is a major investment of Medical Marijuana, Inc. ( OTC PINK : MJNA ), the first publicly traded cannabis company ……

Read More

June 20, 2017

AXIM® Biotechnologies Secures Funding to Advance Clinical Trials and Bioequivalency Study

MedChew Rx™ is a THC/CBD controlled-release chewing gum, which is undergoing clinical research to treat pain and spasticity in MS patients….

Read More

March 28, 2017

Destacada inversión de Medical Marijuana, Inc. en AXIM Biotech

Nuestros productos destacados incluyen CanChew®, un chicle de liberación controlada basado en CBD, además de MedChew Rx, una combinación ……

Read More

March 9, 2017

Axim Biotechnologies Inc (OTCMKTS:AXIM) Just Kicked Off A Value Driving Trial

Well, as mentioned, it's a cannabis based chewing gum, and it's called CanChew Plus Cannabidiol (CBD). The CanChew brand is something we've ……

Read More

Medical Marijuana, Inc. Investment AXIM® Biotech Announces Enrolled Patients Begin Phase II …

NEW YORK, March 7, 2017 /CNW/ — Medical Marijuana, Inc. (OTC: MJNA), … bowel syndrome (IBS) with the company's CanChew Plus® CBD…

Read More

March 8, 2017

AXIM® Biotech, la inversión de Medical Marijuana, Inc., anuncia que los pacientes seleccionados …

… basados en el cannabis. Sus emblemáticos productos incluyen la CanChew Plus®, una goma de mascar a base de CBD de liberación…

Read More

January 21, 2017

AXIM® Biotech, compañía de inversión de Medical Marijuana, Inc., llega a un ensayo bioclínico …

AXIM va a utilizar el chicle que contiene 50mg de CBD por toma durante el ensayo, y se permitirá que los pacientes…

Read More

January 20, 2017

AXIM® Biotech Enters Groundbreaking Clinical Trial Of CBD Gum And IBS

CBD is a nonpsychoactive phytocannabinoid, a unique organic chemical found in the cannabis plant. The natural compound is one of several that…

Read More

January 19, 2017

Medical Marijuana, Inc. Investment AXIM® Biotech Enters IBS Clinical Trial With CBD Chewing Gum

… from the Medical Ethical Committee (METC) at Wageningen University for the trial using controlled-release hemp oil CBD chewing gum with patients ……

Read More

Medical Marijuana, Inc. Investment AXIM® Biotech Enters IBS Clinical Trial With CBD Chewing Gum

19, 2017 /PRNewswire/ — Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that ……

Read More

January 7, 2017

Wall Street Analysts Rank Medical Marijuana, Inc. and AXIM® Biotechnologies Among Top 10 …

High Times Magazine features Medical Marijuana, Inc. and AXIM® … CBD-Based Cannabis Products Available to All Florida Customers, Despite Law ……

Read More